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Abstract
Contamination of potentially carcinogenic hexavalent chromium (Cr(VI)) in the drinking
water is a major public health concern worldwide. However, little information is available
regarding the biological effects of a nanomoler amount of Cr(VI). Here, we investigated the
genotoxic effects of Cr(VI) at nanomoler levels and their repair pathways. We found that
DNA damage response analyzed based on differential toxicity of isogenic cells deficient in
various DNA repair proteins is observed after a three-day incubation with K2CrO4 in REV1-
deficient DT40 cells at 19.2 μg/L or higher as well as in TK6 cells deficient in polymerase
delta subunit 3 (POLD3) at 9.8 μg/L or higher. The genotoxicity of Cr(VI) decreased ~3000
times when the incubation time was reduced from three days to ten minutes. TK mutation
rate also significantly decreased from 6 day to 1 day exposure to Cr(VI). The DNA damage
response analysis suggest that DNA repair pathways, including the homologous recombina-
tion and REV1- and POLD3-mediated error-prone translesion synthesis pathways, are criti-
cal for the cells to tolerate to DNA damage caused by trace amount of Cr(VI).
Introduction
Chromium (Cr) is a naturally occurring element that exists in a variety of oxidation states
between -2 to +6. Among these forms, Cr(III) is an essential trace element for normal
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carbohydrate, lipid and protein metabolism in humans [1]. On the other hand, Cr(VI) has
been reported to cause cancer in laboratory animals and occupationally exposed workers [2]
and thus draws great attention as a public health concern. Cr(VI) is widely used in various
industrial applications including leather tanning, wood preservation, dye production, chrome
plating, and alloy manufacturing. Industrial waste containing Cr(VI) may potentially result in
the environmental pollution of soil, water and air. Incineration and gasoline usage can also
lead to air and water pollution with Cr(VI) as a contaminant. In addition, Cr(VI) can be pro-
duced naturally. For example, Cr(III) can be oxidized by Mn(III/IV) into Cr(VI) [2]. Cur-
rently, there are hundreds of Superfund sites in the U.S. in which Cr is the major concern for
contamination [3].
When taken up by sulfate channels, Cr(VI), which displays no direct DNA damage capabil-
ity by itself, is reduced by ascorbate, glutathione, and cysteine, producing reactive intermedi-
ates of Cr(V), Cr(IV) and reactive oxygen species (ROS) [4]. Cr(III), the final reduction
product, can hardly penetrate the cytoplasmic membrane, thus leading to the massive accumu-
lation of Cr inside of cells [2]. The reactive intermediates of Cr has been proposed to induce
Cr-DNA adducts and protein-Cr-DNA crosslinks, thereby causing DNA strand breaks and
double strand breaks and eventually introducing mutations and genome instability [2]. Besides
Cr, ROS can also induce cytotoxicity and mutagenic effects in cells [4]. Due to its genotoxicity,
inhaled Cr(VI) was classified as a known human carcinogen by the United States Environmen-
tal Protection Agency (U.S. EPA) and the World Health Organization (WHO). With regard to
carcinogenicity of Cr(VI) by ingestion, on the other hand, several of the epidemiological stud-
ies present contradictory conclusions [5, 6]. In the presence of organic molecules at acidic pH,
Cr(VI) can be reduced to non-toxic Cr(III) very quickly, which reduces the concern of Cr(VI)
as an ingested human carcinogen. A National Toxicology Program (NTP) conducted a two-
year study showing that Cr(VI) is a rodent carcinogen when these rodents were administered
extremely high doses (57,300 μg/L or higher) of Cr(VI) in the drinking water [7]. The U.S.
EPA has set the maximum contaminant levels (MCL) for total Cr in the human drinking water
at 100 μg/L. In California, MCL for Cr(VI) was set at 10 μg/L [8], and Public health goals
(PHGs) were established at 0.02 μg/L [9]. Currently the U.S. EPA is re-evaluating these regula-
tions [10]. In 2010, a report by the Environmental Working Group suggests that 89% of the
water samples from U.S. cities are contaminated with Cr(VI) at levels ranging from 0.03 to
12.9 μg/L [11]. The mechanism by which Cr(VI) causes genotoxicity is well characterized at
concentrations equivalent or higher to current U.S. EPA regulatory levels. However, little
information is available regarding the biological effects of Cr(VI) at doses lower than 100 μg/L.
Because of the high level of homologous recombination and the relative ease of gene manip-
ulation, DT40 cells, the chicken B-lymphocyte cells, have been widely used as a model system
for higher vertebrate genetic functional studies [12, 13]. With the fast replication speed and the
strong phenotypic similarities with murine cells, it makes the DT40 isogenic cell line and its
mutants deficient in various genes ideal for reverse genetic studies [14]. Recently, DT40 cells
have also been successfully used to measure the genotoxicity of different chemicals [15–17].
Cells are constantly exposed to both endogenous and exogenous agents that may cause
DNA damages, of which if not repaired might cause genome instability and induce mutations
or cell death. Cells have developed multiple mechanisms to deal with different types of DNA
damages[18]. Nucleotide excision repair [19] and Fanconi anemia genes [20] were previously
reported to be essential for the removal of Cr(VI)-induced DNA damage or activated in
human cells exposed with Cr(VI). Inter-strand DNA cross-links (ICLs) was reported caused
by Cr(VI) exposure in the present of glutathione, one report suggests FANCD2, ERCC1 or
XPF doesn’t impact cell sensitivity to Cr(VI)[21]. Non-homologous end-joining (NHEJ) repair
pathways[22] was reported to be involved into the removal of Cr(VI) induced DNA damaged
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in Saccharomyces cerevisiae and HR repair pathways were reported to be involved into the
removal of Cr(VI) induced DNA damage in mammalian cells[23]. The Werner Syndrome
Protein was also reported to be involved into Cr(VI) induced DNA damage[24]. To further
investigate the mechanism of Cr(VI) induced DNA damage and repair pathways, in this study
we screened a battery of DT40 mutant cells using genotoxicity profiling and found the DNA
repair genes and pathways to be critical for cell survival when these cells were exposed to Cr
(VI) at nanomolar concentrations. We also confirmed our results using human cancer knock-
down cells and further studied the time- and dose- dependent genotoxicity and mutagenicity
of nanomolar concentrations of Cr(VI).
Materials and Methods
Chemicals and reagents
The following chemicals and reagents were used in the study: potassium chromate (K2CrO4,
Sigma), 2,3-bis[2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide inner salt
(XTT) (Sigma), polybrene, puromycin (Sigma), 1-methoxy-5-methylphenazinium methyl
sulfate (Sigma), TRIzol1 RNA Isolation Reagent (Invitrogen), RPMI 1640 culture medium
(Invitrogen), chicken serum (Invitrogen), penicillin/streptomycin (Invitrogen), fetal bovine
serum (FBS) (Atlanta Biologicals), iScript™ cDNA Synthesis Kit (Bio-Rad Laboratories, Inc.),
SsoAdvanced™ Universal SYBR1 Green Supermix (Bio-Rad), and TransIT1-293 transfection
reagent (Mirus Bio LLC).
Cell culture
Chicken DT40 and mutant cells were maintained as described previously [17]. Briefly, DT40
cells were maintained in non-phenol red RPMI 1640 medium with 10% fetal bovine serum,
1% chicken serum and 1% penicillin/streptomycin. The cells were incubated at 39.5˚C and 5%
CO2 with 95% humidity. The source of all DT40 knockout mutant cells is provided in Table 1
in S1 File. Human lymphoblastoid (TK6) cells were kindly provided by Dr. Rebecca Fry (Uni-
versity of North Carolina at Chapel Hill). HeLa and 293T cells were obtained from the Line-
berger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill. TK6
cells were maintained in RPMI 1640 medium with 10% fetal bovine serum and 1% penicillin/
streptomycin. HeLa and 293T cells were grown in DMEM medium supplemented with L-glu-
tamine, 10% fetal bovine serum and 1% penicillin/streptomycin. All human cells were main-
tained at 37˚C with 5% CO2.
Lentiviral-mediated RNA interference
All short oligonucleotides used for lentiviral plasmids were purchased from Thermo Fisher
Scientific Inc. and were inserted into the PLKO.1-puromycin vector. Lentiviral particles were
prepared and target cells were infected according to a standard protocol. Briefly, 2μg PLKO.1,
2μg pREV, 2μgpGag/Pol and 1μg pVSVG were transfected with TransIT1-293 transfection
reagent into HEK293T cells in a 6cm dish. Cell culture medium was changed 24 hours later,
and the supernatant containing lentiviral particles was collected 2 days after transfection. Tar-
get cells were infected with lentivirus in the presence of 5 μg/ml polybrene, and after 24 hours
of incubation fresh medium with puromycin was used. 2–3 days later, resistant cells were used
directly (BRCA1 and RAD54) or monoclonal colonies (POLD3) were collected. Knockdown
efficiency was checked by qPCR. Details of shRNAs are provided in Table 2 in S1 File.
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Analysis of DT40 cell-based DNA damage response
The DT40 cell-based DNA damage response was analyzed as previously reported [17] with
minor modifications. Briefly, DT40 cells were suspended in culture medium (~750 cells per
75 μL per well), seeded into 96-well plates, exposed to K2CrO4, and allowed to divide for ~7
cell cycles. After cultivation, cell viability was determined by XTT-based cell viability assays.
TK mutation assay
The thymidine kinase locus gene (TK) mutation assay was performed to quantify mutagenicity
(214074). Background TK gene mutants were removed from TK6 cells by growing them for 2
days in media containing CHAT followed by incubation for 1 day in media containing CHT.
Cells were then seeded at 2.7×105 cells/ml in 20 ml serum containing media and were exposed
to Cr6 for different periods. Following K2CrO4 incubation, cells were washed three times with
sterile PBS, re-suspended in full serum containing media and cultured for 2 days to allow the
development of mutations. The cells were maintained at 1.5 × 106 cells/ml or lower to avoid
overgrowth. The cells were harvested by centrifugation, re-suspended in fresh media. For the
TK-deficient mutant selection, the cells were cloned into 96-well plates at 40,000 cells/well in
growth medium (0.125 ml) in the presence of the selective agent trifluorothymidine (TFT,
final concentration 4 μg/ml) for the detection of mutation frequency (MF). Cells were also
seeded at a density of 1.0 cells/well into 96-well plates in the absence of TFT to determine plat-
ing efficiency (PE). The plates were incubated at 37˚C in an atmosphere of 5% CO2 for 14
days. The colony formation was then scored. The plates containing TFT were then re-fed with
TFT and incubated for an additional 14 days to score for the appearance of slow-growing TK
mutants. The total mutation frequencies were calculated according to the Poisson distribution.
qPCR analysis
Total RNA was isolated using TRIzol1 RNA Isolation Reagents, and an equivalent amount of
RNA from each sample was used as template to make cDNA using the iScript™ cDNA Synthe-
sis Kit. qPCR was performed according to the standard protocol using SsoAdvanced™ Univer-
sal SYBR1 Green Supermix. Primers used in this study were listed in Table 2 in S1 File. Data
were analyzed by ΔΔCt method for relative quantifications, actin was used as internal control.
Statistical analysis
Data are reported as the mean ± standard deviation of at least triplicate samples. Analysis of
covariance (ANCOVA) was used to test for mean intercept differences and differences in the
slopes of the linear dose-response curves in cell viability analyses between wild-type and a
series of mutant cells. For display purposes, survival data were log-transformed, providing
approximately normal errors, to calculate the lethal concentration 50 (LC50) values for each
cell line using Graphpad Prism 5 (La Jolla, CA). P-values were two sided and adjusted for mul-
tiple comparisons as noted.
To represent the point of departure values for concentration-response, Benchmark dose
(BMD) values [25] were obtained from the EPA BMD software v 2.4. These values represent
one-standard deviation departures from control values and corresponding lower 5% BMDL
values, using log10(concentration+0.5) to avoid taking logarithms of zero control values. For
each instance, the best fitting result from Hill, exponential and polynomial response non-con-
stant variance models was used. In several instances, the fit was considered marginal by BMD
information criteria, and therefore we devised a 4-parameter robust logistic model, fit by
maximum likelihood in R v3.01, to augment the analyses. In no instance was the BMD value
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determined from the logistic model outside of the 90% confidence interval reported by the
BMD software.
Comparisons of BMD values from independent concentration-response curves were per-
formed using z-statistics computed as z ¼ ðBMD1   BMD2Þ=
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SE2
1
þ SE2
2
p
; with standard
errors inferred from the BMD confidence interval. One-sample t-tests were performed for
comparisons of LC50 across the cell lines in comparison to DT40 wilt-type cells using ratio val-
ues and in comparison to a null ratio of 1.0.
Results
Chicken DT40 cells deficient in either homologous recombination or the
error-prone translesion synthesis pathway are hyper-sensitive to Cr(VI)
To first determine the cytotoxicity of Cr(VI), we exposed chicken DT40 cells, a frequently
used cell line for understanding DNA repair gene function studies, with Cr(VI) salt K2CrO4 at
various concentrations ranging from 1 to 2000 μg/L for approximately three consecutive days.
We examined cell survival rate as a result of Cr(VI) treatment. The DNA damage response is a
very broad term for the network of cellular pathways that sense, signal and repair DNA lesions.
In the current study we use cell survival rate as an indication of toxicity and DNA damage
response as shown previously [17]. At the dose of 100 μg Cr/L (equivalent to 373 μg K2CrO4/
L), which is the MCL for total Cr in drinking water as set by the U.S. EPA, DT40 cells showed
substantial toxicity with ~50% survival rate compared with vehicle-treated cells. Breaking
points (departure points from 100% survival rate) were detected at doses ranging between 20–
80 μg K2CrO4/L (Fig 1A).
Cr(VI) exposure appears to lead to Cr-DNA adducts, protein-Cr-DNA crosslinks, or oxida-
tive DNA damage resulting in genotoxicity [2]. Because DNA repair pathways are important
for maintenance of genomic integrity, we hypothesized that cells deficient in a certain DNA
repair pathway may show altered tolerance to K2CrO4 treatment relative to wild type cells. To
test this hypothesis, a DNA damage response analysis for K2CrO4 using isogenic DT40 mutant
cells was conducted in this study. DNA repair pathways screened in this study include base
excision repair (BER), nucleotide excision repair (NER), mis-match repair (MMR), homolo-
gous recombination (HR), nonhomologous end joining (NHEJ), translesion DNA synthesis
(TLS), Fanconi anemia DNA repair pathway, cell-cycle checkpoint and RecQ helicases. The
whole list and function of each gene is shown in Table 1 in S1 File.
Testing these mutant cells allowed us to identify the DNA repair pathways that are critical
for cell survival in response to K2CrO4 exposure. For a quantitative comparison of differential
toxicity between each mutants, we calculated the relative LC50 (LC50 of mutant cells divided by
the LC50 of the parental DT40 cells). During this screening, we identified four genes, deletion
of any one of which led to hypersensitivity of the cells to K2CrO4 treatment and significantly
reduced the relative LC50 compared to parental DT40 cells (Fig 1D). These include two genes
involved in tanslesion DNA synthesis (TLS), REV1 (relative LC50 = 0.22, p<0.05) and POLD3
(relative LC50 = 0.51, p<0.05), and two genes involved in homologous recombination, BRCA1
(relative LC50 = 0.33, p<0.05) and RAD54 (relative LC50 = 0.44 p<0.05) (Fig 1B and 1D).
Among these four mutant cell lines, REV1-deficient DT40 cells are most sensitive to K2CrO4
treatment with an LC50 at 66 μg/L and a breaking point of cell survival at 19 μg/L (= 5.2 μg Cr/
L) compared with LC50 at 400 μg/L and breaking point at 95 μg/L (= 25 μg Cr/L) in wild type
DT40 cells (p<0.0001) (Fig 1C). These results suggest that DNA repair pathways, including
the homologous recombination and the error-prone translesion synthesis pathways, are criti-
cal for DT40 cells to tolerate genotoxicity induced by Cr(VI). It is also worth noting that
MSH3 deficient cells show hyposensitivity to Cr(VI) exposure (Fig 1D). Beside these hyper-
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Fig 1. K2CrO4 reduces viability of human cells as well as DT40 cells deficient in certain DNA repair pathways at the maximum
contaminant levels (MCL) set by the U.S. EPA. Various human cells (A) and DT40 parental cells and their mutant cells (B) deficient in
REV1, BRCA1, or RAD54 were exposed to K2CrO4 for ~3 days to determine their survival rates. Survival data were log-transformed giving
approximate normality using Prism 5. Each LC50 value was then calculated. The black arrow indicates the maximum contaminant levels
(MCL) set by the U.S. EPA, while the open arrow shows the highest Cr(VI) levels detected in U.S. city water (12.9 μg/L). (C) Point-of-
departure analysis showed a significant difference (p<0.0001) in DT40 (log10(BMD) = 1.98 by the Hill model) vs. REV1-deficient cells (log10
(BMD) = 1.28 (19.2 μg/L) by the Hill model). (D) DT40 cell-based DNA damage response analysis was performed for K2CrO4 using a series
of DT40 mutants. Relative LC50 values were normalized according to the LC50 value of the parental (wild type) DT40 cells. Error bars
Genotoxicty of Trace Levels of Cr(VI)
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and hypo-snsitivity results, DT40 cell-based DNA damage response analysis demonstrate
moderate sensitivity to K2CrO4 in various mutants including cells deficient in XRCC2,
FANCL, FANCI, BLM, WRN, KU70,DNAPKcs, LIGIV, RAD18, FEN1, PARP1, and XPA.
Cr(VI) exposure leads to genotoxicity in human cells
While DT40 cells offer a relatively quick and facile method to analyze the DNA damage
response to chemicals, one concern of this approach is that the effects observed in chicken
cells may not replicate those in human cells. Therefore, we examined the genotoxicity of
human cells induced by Cr(VI). As with DT40 cells, we continuously exposed several different
lines of human cells including HeLa (cervical carcinoma epithelial cell line), 293T (kidney epi-
thelial cell line) and TK6 (B-lymphoblast cell line) cells to Cr(VI) salt K2CrO4 at various con-
centrations for three days and subsequently assessed cytotoxicity. Similar to DT40 cells, all of
the human cell lines tested in this study showed a marked toxic response to Cr(VI) at 373 μg
K2CrO4/L (= 100 μg Cr/L) with survival rate of 50%, 17%, and 10% for HeLa cells, 293T and
TK6 cells, respectively) (Fig 1A). We next investigated the DNA damage response of Cr(VI)
exposure in human cells deficient in DNA damage repair genes. Since BRCA1, RAD54,POLD3
and REV1 are the genes most critical for chicken DT40 cell survival in the presence of Cr(VI),
we investigated whether these genes are also critical for human cell survival. Knockdown of
BRCA1, RAD54, and POLD3 in human cells was successfully established by lentiviral-mediated
RNA interference (Fig 1 in S1 File). However, knockdown of REV1 led to severe cell death,
and we were unable to carry out any further experiments using REV1-deficient cells (data not
shown). Similar to DT40 mutant cells, human cells deficient in POLD3, RAD54 or BRCA1
were also more sensitive to Cr(VI) than wild type cells infected with a non-target control virus,
as indicated by reduced cell viability (Fig 2). BRCA1-deficient HeLa cells showed toxicity with
an LC50 of 52 μg/L, and RAD54-deficient HeLa cells showed toxicity with an LC50 of 79 μg/L
compared with control HeLa cells with an LC50 of 358 μg/L (Fig 2A). POLD3-deficient TK6
cells showed toxicity with an LC50 of 39 μg/L and a breaking point at 9.8 μg/L (= 2.6 μg Cr/L)
compared with control TK6 cells with an LC50 of 104 μg/L and a breaking point at 34 μg/L
(= 9.0 μg Cr/L) (Fig 2B and 2C). Based on the results from the DT40 mutant cells and human
mutant cells, we concluded that trace amount of Cr(VI) have the potential to cause a DNA
damage response and genotoxicity during a three day continuous exposure, and homologous
recombination (BRCA1 and RAD54) and error-prone translesion synthesis (REV1 and
POLD3) are critical for cells to tolerate nanomolar levels of Cr(VI)-induced genotoxicity.
Cr(VI) exposure-induced genotoxicity is both time and dose dependent
It has been reported that efficient uptake of Cr(VI) into cells results in a massive accumulation
of intracellular Cr during continuous 24-hour exposure [2, 26, 27]. Therefore, we hypothesized
that trace amounts (i.e. nanomolar levels) of Cr(VI) exposure leads to a DNA damage response
only by long-term, and probably not by short-term, incubation of K2CrO4. To address this
possibility, we incubated the most sensitive mutant cells observed in our study, REV1-deficient
DT40 cells, with K2CrO4 for durations of 10 min to 8 hours followed by extensive washing of
the cells to minimize residual extracellular K2CrO4 levels. The cells were further incubated for
3 days in fresh media before assessing cell survival rate. REV1-deficient DT40 cells showed a
represent standard deviation from at least three independent experiments. Student’s t-test was used to test for significance in mean LC50
values between DT40 parental cells and each mutant. Columns shaded in gray indicate significant differences (p<0.05) between parental
DT40 cells and each mutant. Columns shaded in black show the cell lines (REV1, RAD54, POLD3, and BRCA1 mutants) that are markedly
sensitive to K2CrO4. (p<0.05 for all four cell lines after Bonferroni adjustment for 32 tests).
doi:10.1371/journal.pone.0167503.g001
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drastic time-dependent increase in cell toxicity caused by K2CrO4 (Fig 3A). A ten-minute
K2CrO4 exposure resulted in cell toxicity with an LC50 of ~24 x 10
3 μg/L, which is 465 times
higher (less toxic) than a three-day continuous K2CrO4 exposure (Fig 3A). We further found a
highly significant linear relationship between log-transformed incubation time and LC50
Fig 2. K2CrO4 reduces the viability of human cells deficient in certain DNA repair pathways at Cr(VI) levels detected in U.S. city
water. HeLa cells (A) and TK6 cells (B) transiently or stably knocked down with shRNA against RAD54, BRCA1, or POLD3 were exposed to
K2CrO4 for ~3 days to determine their survival rate. (C) Point of departure analysis of TK6 indicated significant differences (p<0.0001) for
TK6 control (log10(BMD) = 1.53, exponential model) vs. POLD3 shRNA knock down (log10(BMD) = 0.99 (9.8 μg/L), polynomial model). The
black arrow indicates the maximum contaminant levels (MCL) set by the U.S. EPA. The open arrow shows the highest Cr(VI) levels detected
in US city water.
doi:10.1371/journal.pone.0167503.g002
Genotoxicty of Trace Levels of Cr(VI)
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Fig 3. The genotoxicity of K2CrO4 in human and DT40 cells is drastically decreased when K2CrO4
incubation time is reduced. (A) REV1 ko DT40 cells were incubated with K2CrO4 for 10 min to 8 hours
followed by extensive washing. The cells were further cultivated for 3 days in fresh medium without addition of
K2CrO4 to determine cell survival. (B) The exposure times (hours) were multiplicatively inversed followed by
log transformation (x-axis). LC50 data for each exposure time were log transformed (y-axis). Linear regression
analysis was performed to determine the relationship between exposure time and LC50 values (p<0.0001).
(C) TK6 POLD3 knock-down cells and TK6 mock shRNA-treated cells were incubated with K2CrO4 for 10 min
Genotoxicty of Trace Levels of Cr(VI)
PLOS ONE | DOI:10.1371/journal.pone.0167503 December 1, 2016 9 / 16
values (Fig 3B). Wild type TK6 cells also showed a time dependent toxicity with ~3000-fold
higher LC50 value upon ten-minute K2CrO4 exposure than a three-day incubation (Fig 3C). It
is worth noting that, under these experimental conditions, wild type and POLD3-deficient
TK6 cells showed significantly different LC50 values (Fig 3C). Upon 10 minute exposure to
K2CrO4, the LC50 value is ~403 x 10
3 μg/L for wild type cells and ~94 x 103 μg/L for POLD3-
deficient cells. Upon exposure of cells to K2CrO4 for 3 days, the LC50 value is 135 μg/L for wild
type cells and 48 μg/L for POLD3-deficient cells. Since POLD3 is involved in DNA damage
repair, our results suggest that K2CrO4 treatment leads to a time-dependent increase in induc-
tion of DNA damage in human cells.
The mutagenicity of Cr(VI) in human TK6 cells is both time and dose
dependent
Finally, we examined the mutagenic activity of K2CrO4 and asked whether this activity is time
and dose dependent. We exposed human TK6 cells with K2CrO4 at 180,000 μg/L for 10 min.
This concentration of K2CrO4 is very close to Cr(VI) concentration which has been reported
to cause oral and intestine cancers by drinking water in rodents [7]. We found that this
K2CrO4 exposure led to about a two fold increase in the TK gene mutation frequency of TK6
cells compared to that of vehicle-treated cells (Fig 4B). A similar increase in TK gene mutation
was detected when cells were treated with K2CrO4 at a concentration between 100 and 200 μg/
L for 24 hours (Fig 4C), which is more than three orders of magnitude lower in concentration
compared to a 10 min exposure with 180,000 μg/L K2CrO4 (Fig 4B). We then examined
whether prolonged exposure to K2CrO4 at levels as low as the highest level of contamination
found in U.S. city water caused mutations in TK6 cells [11]. Cell growth inhibition in wild-
type TK6 cells started at 1, 3, and 5 days when the cells were continuously exposed to K2CrO4
at 100, 50, and 25 μg/L, respectively (Fig 4A). TK mutation frequency was markedly increased
as exposure time increased from 1 day to 6 days with different threshold levels for each expo-
sure condition (Fig 4C). These results clearly show that the genotoxicity introduced by Cr(VI)
is dependent on both the concentration of Cr(VI) and the total exposure time. Our data also
indicate that short-term Cr(VI) exposure is markedly less genotoxic than chronic exposure at
the same Cr(VI) concentration.
When comparing a 6-day K2CrO4 exposure to a 14-day K2CrO4 exposure, a drop in the
mutation rate observed in the 14-day rate for the lowest active produced an apparent differ-
ence in point of departure BMD values (p<0.05), however, after eliminating this point there
was no evidence of a difference in mutation rates between 6-day and 14-day exposures (Fig
4D). Combining the mutation frequency results from 6- and 14-day K2CrO4 exposures, a sig-
nificant increase in mutation rate was observed at 12.5 μg/L (= 6.7 μg Cr(VI)/L) or higher as
compared to controls in TK6 cells (Fig 4E). These results suggest that cells may be equipped
with a mechanism to tolerate further increases in mutations caused by trace amounts (25 μg/L
or lower) of K2CrO4 for exposure periods of longer than 6 days.
Discussion
In the current study, we investigated the genotoxicity of low dose Cr(VI) in cultured chicken
DT40 cells and human cells. We found that the genotoxicity of cells exposed to nanomolar
followed by extensive washing. The cells were further cultivated for 3 days in fresh medium without addition of
K2CrO4 to determine cell survival. The survival curves were compared between 10-min and 3-day exposure
groups (p<0.0001). The green arrow indicates the Cr(VI) concentration (172,000 μg/L) that causes an
increase in oral cancer, a finding that was previously shown in an NTP rodent study [7].
doi:10.1371/journal.pone.0167503.g003
Genotoxicty of Trace Levels of Cr(VI)
PLOS ONE | DOI:10.1371/journal.pone.0167503 December 1, 2016 10 / 16
Fig 4. The mutagenicity of K2CrO4 in human TK6 cells is markedly decreased by reducing K2CrO4
incubation time. (A) Cumulative cell growth rates of TK6 cells were monitored during continuous incubation with
K2CrO4 at different concentrations for up to 6 days. (B) Mutation rates of TK6 cells exposed to K2CrO4 for 10 min.
After extensive washing, the cells were further cultured for 3 days for the phenotype expression period, followed by
a mutant selection process using trifluorothymidine (TFT). The two groups show significantly different mutation
rates (p<0.0001). (C) Mutation rates of TK6 cells exposed to K2CrO4 for 1 or 6 days. For 1-day exposure
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levels of Cr(VI) is both time and dose dependent, with higher dose or longer exposure leading
to severer genotoxicity. We also identified four key components of DNA repair proteins,
REV1, POLD3, BRCA1 and RAD54, that are critical for tolerating the genotoxicity induced by
Cr(VI). In addition, we found that prolonged (1–2 weeks) exposure to trace amounts (~10 μg/
L) of K2CrO4 causes increased mutations in human lymphoblastoid cells. However, the geno-
toxicity of Cr(VI), including the DNA damage response and mutagenesis, decreased ~3000
times when the incubation time was shortened from three days to 10 minutes. Our dose- and
time-dependent Cr(VI) genotoxicity results, combined with the quick transit time of Cr(VI) in
the digestive tracts of animals after drinking Cr(VI)-contaminated water could explain carci-
nogenicity of Cr(VI) in drinking water in rodents only at super high concentrations.
Nucleotide excision repair, but not Fanconi anemia pathway, plays
critical roles on the tolerance to DNA lesions caused by K2CrO4 in DT40
cells
While Cr(VI) is not reactive to DNA under physiological conditions, the intracellular reduc-
tion of Cr(VI) towards Cr(III), leading to cause DNA damage[28]. The DNA lesions produced
through reduction of Cr(VI) include, single and double strand breaks[29], oxidative DNA
damage[28, 30, 31], ternary complex of endogenous reducing agent-Cr-DNA phosphodiester
backbone[28, 32], Cr-DNA interstrand crosslinks [33] and DNA-Cr-protein crosslinks [34].
Among various DNA repair pathways for counteracting these DNA lesions, nucleotide exci-
sion repair pathway has been reported to be important for the removal or tolerance of Cr(VI)-
induced DNA damage [19, 35–37]. In an agreement with these reports, K2CrO4 caused higher
toxicity in DT40 cells deficient in XPA compared to parental DT40 cells.
Fanconi anemia cells are well-known to be hyper-sensitive to DNA interstrand and DNA-
protein crosslinking agents such as cisplatin, diepoxybutadiene, and formaldehyde [38, 39].
Previous report showed that FANCA-deficient cells are hyper-sensitive to Cr(VI) in cell sur-
vival with S-phase-dependent DSB formation using none-isogenic cell lines and Cr(VI) also
induced FANCD2 monoubiquitination [20, 40]. However, other group’s report demonstrated
conflicting results using isogenic cultured cells in the presence of physiological levels of ascor-
bic acid, which is a critical reducing element for Cr(VI)-induced DNA crosslinking lesions in
vitro [21]. In the DT40 cell-based DNA damage response analysis, we found that the cells defi-
cient in FANCD2 and FANCG were not hypersensitive to K2CrO4 treatment with marginal
sensitivity in cells deficient in FANCI and FANCL. Our results suggest that DNA crosslinks are
not major contributors to the DNA damage response caused by trace amounts of Cr(VI) in the
DT40 cell system under the condition we utilized.
experiments, the TK6 cells were treated with K2CrO4 for 24 hours followed by washing and 2-day phenotype
expression period before TFT treatment (log10(BMD) = 2.01, Hill model). For 6-day exposure experiments, we
continuously treated the cells with K2CrO4 for 6 days by adding fresh K2CrO4 into the culture medium when the cells
were subcultured. After the 6-day treatment, the cells were treated with TFT (log10(BMD) = 1.48, Hill model). The
number of mutants was counted at 2 and 4 weeks after the first TFT treatment. Error bars represent standard
deviation around the mean obtained from at least three independent experiments. The 1-day and 6-day BMD
values are significantly different (P = 0.005). (D) Dose-response curves of mutation rates of TK6 cells exposed to
trace amounts of K2CrO4 were compared between 1-, 6- or 14-day treatment groups. For 1-day and 6-day
exposures, the mutation assays were performed as described in Fig 4C. For 14-day exposure experiments, the
assays were conducted as described in the 6-day experiment except that the duration of K2CrO4 treatment was
prolonged. Error bars represent standard deviation around the mean obtained from at least three independent
experiments. (E) Since 6- and 14-day dose-response curves overlapped with each other in mutation rates and there
was no significant difference between the mutation rates above the second active concentration, the mutation rate
data were combined and analyzed as pooled results. (log10(BMD) = 1.02 (10.5 μg/L), Hill model).
doi:10.1371/journal.pone.0167503.g004
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HR and TLS are critical for tolerating Cr(VI) exposure
In our DNA damage response assay using a battery of DT40 cells deficient in DNA repair
genes, we found that REV1, BRCA1, RAD54, and POLD3 are essential in rescuing Cr(VI)-
induced DNA damage. This finding suggests that homologous recombination and the error-
prone translesion synthesis are critical for DT40 cells to tolerate DNA damage caused by trace
levels of Cr(VI). We have confirmed these results using human knockdown cells. Previous
reports also demonstrated similar results using Saccharomyces cerevisiae deficient in various
DNA repair genes with higher sensitivity of Rad18 Rad27, Rad50, Rad51, Rad52, Rad54,
Rad59, Rev3, and Rev1mutants to either Na2CrO4 or CrO3 [41, 42] compared to their wild-
type cells. Homologous recombination is one of two primary DSB repair pathways and utilizes
a series proteins including ATM, RAD54, and BRCA1 for repairing DSBs during S and G2
phases [18]. The mechanism by which Cr(VI) causes replication-associated DNA DSBs [43]
appears to be due to the collapse of replication fork as well as conversion of single strand break
to DSBs.
We found DT40 cells deficient in REV1 is the most sensitive cell line to K2CrO4 among
DT40 mutants utilized in this study. As described above, yeast study also showed higher toxic-
ity in the yeasts deficient in RAD18, REV3, and REV1 [41, 42]. In addition, our study demon-
strated POLD3-deficient cells were hyper-sensitive to K2CrO4 with moderate toxicity of
RAD18 mutant cells. POLD3 is one of the subunits of replicative DNA polymerase delta and
POLD2-POLD3 complex is believed to be involved in TLS by switching binding between POL-
D1and translesion polymerase REV3 when encountered with DNA replication barrier [44,
45]. Besides, in our preliminary data PCNA mono-ubiquitination deficient mutation cells
shows similar Cr(VI) sensitivity with REV1 deficient cells and REV1 C-terminal is critical for
REV1’s function to tolerate Cr(VI) toxicity but not REV1 catalytically domain. Taken together,
we are proposing the following mechanism of bypassing K2CrO4-mediated DNA lesions by
TLS pathway: 1) ternary Cr-DNA lesions stall DNA replication and activate RAD18-mediated
TLS pathway; 2) RAD6-RAD18 complex monoubiquitinates PCNA; 3) low-fidelity TLS poly-
merase bypass DNA lesions in the presence of scaffold protein REV1, leading to mutations;
and 4) REV3 further extends DNA synthesis with POLD2 and POLD3 complex. It is worth-
while to note that previous paper reported polymerase zeta-dependent chromium-induced
mutagenesis in yeasts [46]. As with REV3, in the absence of either REV1, or POLD3, we believe
Cr(VI)-mediated mutagenesis may be significantly decreased.
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